Startups

Biobeat: $50 Million Series B Secured To Expand U.S. Commercialization Of Cuff-Less 24-Hour Blood Pressure Monitoring

By Amit Chowdhry ● Today at 9:52 AM

Biobeat Technologies announced it has closed a $50 million Series B equity financing to accelerate commercialization of its FDA-cleared, cuff-less 24-hour ambulatory blood pressure monitoring (ABPM) system in the United States.

CHAMP Titles: $55 Million Raised To Build Digital Systems For Motor Vehicle Agencies

By Amit Chowdhry ● Today at 9:47 AM

CHAMP Titles, a Cleveland-based provider of digital systems for U.S. motor vehicle agencies, announced it raised $55 million in new financing, marking its largest funding round to date and pushing total capital raised to more than $100 million.

Traini: $7.5 Million Raised To Build Pet Emotional Intelligence Platform

By Amit Chowdhry ● Dec 29, 2025

Traini, a Palo Alto-based startup focused on “pet emotional intelligence,” announced it has raised $7.5 million to develop AI systems that interpret pet emotions and intentions and translate them into human-understandable language through real-time, two-way interaction.

Dentira Raises Strategic Growth Funding From Vista

By Amit Chowdhry ● Dec 29, 2025

Dentira, a procurement and spend management software provider for dental practices and multi-site healthcare operators, said it has secured a strategic growth investment from Vista Equity Partners. Terms of the transaction were not disclosed.

Lucidean: $18 Million Seed Funding Raised To Scale CohZero Data-Center Optics

By Amit Chowdhry ● Dec 26, 2025

Lucidean, a Santa Barbara, California–based AI interconnect company developing coherent optical links for data centers, has raised $18 million in Seed financing and appointed Dr. James Raring as chief executive officer.

Clarity Pediatrics: $14.5 Million Series A Raised To Expand Virtual Chronic Care Platform Into Pediatric Obesity Services

By Amit Chowdhry ● Dec 26, 2025

Clarity Pediatrics, a telehealth company focused on virtual specialty care for chronic pediatric conditions, announced it has raised $14.5 million in Series A financing and plans to expand its platform into pediatric obesity care, with an obesity-services launch targeted for early 2026.

Atavistik Bio: $120 Million Series B Raised To Advance Selective Allosteric Small-Molecule Programs In HHT And MPNs

By Amit Chowdhry ● Dec 26, 2025

Atavistik Bio said it raised a $120 million Series B financing to push two selective allosteric small-molecule programs into clinical proof-of-concept studies: an oral, AKT1-selective allosteric inhibitor for hereditary hemorrhagic telangiectasia (HHT) and a JAK2 V617F mutant-selective inhibitor program for myeloproliferative neoplasms (MPNs).

HBox: Strategic Growth Investment Raised From Charlesbank

By Amit Chowdhry ● Dec 26, 2025

HBox, a virtual care platform focused on specialty medical practices, said it has received a strategic growth investment from Charlesbank Capital Partners’ Technology Opportunities Fund II to support expansion of its AI-powered virtual care capabilities and broader initiatives aimed at high-risk chronic condition management. The transaction closed on December 17, 2025, and was announced December 19.

Radiant Raises Over $300 Million To Scale Mass-Production Of Portable Nuclear Microreactors

By Amit Chowdhry ● Dec 26, 2025

Radiant, a company developing factory-built, transportable nuclear microreactors, has raised more than $300 million in a new funding round to expand commercialization efforts and support construction of its planned R-50 manufacturing facility in Oak Ridge, Tennessee. The company said the raise was completed just six months after its Series C and was assembled in a matter of weeks.

Addition Therapeutics: $100 Million Funding Raised To Advance All-RNA PRINT Platform For One-Time Genomic Medicines

By Amit Chowdhry ● Dec 26, 2025

Addition Therapeutics announced it has raised $100 million in financing to date, highlighting progress toward developing one-time genomic medicines for chronic and rare diseases. Based in South San Francisco, the company is building around an all-RNA, non-viral approach that uses lipid nanoparticles (LNPs) to deliver its PRINT platform, short for Precise RNA-Mediated Insertion of Transgenes.

DUX: $9 Million Seed Funding Closed To Bring Agentic Exposure Management To Modern Cyber Defense

By Amit Chowdhry ● Dec 26, 2025

Dux, an agentic exposure management platform designed to keep pace with AI-driven cyberattacks, has emerged from stealth with a $9 million seed financing round led by Redpoint, TLV Partners, and Maple Capital. The company said the round also included participation from cybersecurity executives from CrowdStrike, Okta, and Armis.

Aeovian Pharmaceuticals: $55 Million Series B Raised To Advance AV078 For Tuberous Sclerosis Complex-Related Refractory Epilepsy

By Amit Chowdhry ● Dec 26, 2025

Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company based in Berkeley, California, has closed an oversubscribed $55 million Series B financing to support completion of a Phase 2 proof-of-concept study for its lead candidate, AV078, in tuberous sclerosis complex (TSC)-related refractory epilepsy.

Gambit Cyber: $3.4 Million Seed Funding Raised To Scale Agentic AI-Driven CTEM Platform

By Amit Chowdhry ● Dec 26, 2025

Gambit Cyber, a Leiden, Netherlands-based startup focused on AI-native preemptive cybersecurity, has raised $3.4 million in seed funding to expand its KnightGuard continuous threat exposure management (CTEM) platform. The round was led by Expeditions, with participation from Bitdefender Voyager Ventures, the early-stage investment arm of cybersecurity company Bitdefender.

UTulsa’s Hurricane Ventures Backs Electrolysis Startup Tobe Energy

By Amit Chowdhry ● Dec 26, 2025

The University of Tulsa and its venture fund, Hurricane Ventures, have invested in Tobe Energy, an electrolyzer startup co-founded by UTulsa alumni Colby DeWeese and Caleb Lareau. The funding will support Tobe Energy’s efforts to make clean hydrogen production more cost-effective and efficient, with the broader goal of expanding access to low-emissions hydrogen as part of the transition to a lower-carbon economy.